VYNE CLO shares withheld for RSU tax payment
VYNE Therapeutics Inc.'s Chief Legal Officer and General Counsel, Mutya Harsch, reported a routine tax-related share disposition.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VYNE Therapeutics Inc.'s Chief Legal Officer and General Counsel, Mutya Harsch, reported a routine tax-related share disposition. On the vesting of restricted stock units, 3,464 shares of common stock were withheld by the company to cover tax withholding obligations at a value of $0.6507 per share. This was not an open-market trade. After this tax-withholding event, Harsch directly holds 118,434 shares of VYNE common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 3,464 | $0.6507 | $2K |
Footnotes (1)
- F1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
tax withholding requirements financial
tax-withholding disposition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did VYNE (VYNE) report for Mutya Harsch?
Was the VYNE (VYNE) insider transaction an open-market sale?
What does the Form 4 tax-withholding code F mean for VYNE (VYNE)?
AI-generated analysis. How Rhea-AI works. Not financial advice.